| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.6M | +132.9% | +647.6% |
| Cost of Revenue | $88K | +214.3% | +1053.2% |
| R&D Expense | $269K | -14.1% | +77.9% |
| SG&A Expense | $3.6M | -23.6% | +532.8% |
| Operating Income | $72.1M | +319.3% | — |
| Pre-tax Income | $74.0M | +344.7% | — |
| Income Tax | $17.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Short-term Investments | $1.4M | +131.4% | — |
| Accounts Receivable | $52K | -95.2% | -68.6% |
| Current Assets | $174.4M | +3026.7% | +5504.6% |
| Total Assets | $480.0M | +347.6% | — |
| Current Liabilities | $85.5M | +1563.7% | — |
| Long-term Debt | $131.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.0M | — | — |
| Capital Expenditures | $2K | — | — |
| Investing Cash Flow | -$236.3M | — | — |
| Financing Cash Flow | $249.6M | — | — |
| Free Cash Flow | -$7.0M | — | — |
| +1393.3% |
| — |
| Net Income | $56.0M | +263.1% | — |
| EPS (Basic) | $2.41 | +121.1% | +6125.0% |
| EPS (Diluted) | $1.83 | +117.9% | +4675.0% |
| +519.7% |
| — |
| Total Liabilities | $236.2M | +755.1% | — |
| Stockholders' Equity | $243.8M | +206.2% | +6063.2% |